Home › Therapeutic areas › Cardiovascular › ATTR Amyloidosis
ATTR Amyloidosis (2 companies)
Companies with an active program in ATTR Amyloidosis.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| NTLA | Intellia Therapeutics | CardiovascularImmunology Rare | 2 | NDA Submitted | $1.59B | 3 |
| IONS | Ionis Pharmaceuticals | CardiovascularHematology+5 Rare | 3 | Approved | $6.55B | 29 |
No companies match.